Ganymed Robotics, a Paris, France-based developer of computer vision software and robotics technologies for orthopedic surgeons, raised €21m in the first close of its Series B funding.
The round was led by Cathay Health, with participation of Credit Mutuel Innovation, Kurma Partners, BNP Paribas Développement and internationally renowned surgeons.
The funding will be used to:
– Support Ganymed’s expansion in France and in the United States;
– Finalize the industrial development of its surgical robotic assistant for knee arthroplasty (TKA);
– Accelerate regulatory and marketing developments across geographies;
– Diversify the innovation product pipeline.
Founded in 2018 by Sophie Cahen, co-founder and CEO, Ganymed Robotics is a medical device company developing the next generation of robotic assistance technologies for orthopedic surgery. The first application is a co-manipulated surgical robotic assistant for total knee arthroplasty (TKA). The robot, fully integrated into the workflow, simplifies and increases accuracy of orthopedics.
Ganymed Robotics intends to progressively deploy its technology to address several other orthopedics indications.
The company currently employs 25 people who develop a proprietary technology platform combining computer vision, a branch of artificial intelligence, and mechatronics, in close collaboration with clinicians and advisors.